Bigul

LYKA LABS LTD. - 500259 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyLYKA LABS LTD. 2CIN NO.L24230GJ1976PLC008738 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 63.74 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Kishore P Shah Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Yogesh B Shah Designation: Executive Director and CFO EmailId: [email protected] Date: 27/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
27-04-2023
Bigul

LYKA LABS LTD. - 500259 - Certificate Under Regulation 40(9) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 40(9) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015; a Certificate for the year ended 31st March 2023 issued by M/s. Kaushal Doshi & Associates, Practicing Company Secretary. is enclosed.
25-04-2023
Bigul

LYKA LABS LTD. - 500259 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ipca Laboratories Ltd & PACs
19-04-2023
Bigul

LYKA LABS LTD. - 500259 - Board Meeting Outcome for Outcome Of Board Meeting Held On 18Th April 2023

In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015; the Board of Directors at its meeting held today i.e. 18th April 2023 inter alia considered the allotment and issue of 24,00,000 Equity Shares upon conversion of 24,00,000 Warrants to Ipca Laboratories Limited, a part of 'Promoter Group'.
18-04-2023
Bigul

LYKA LABS LTD. - 500259 - Submission Of Voting Results Of The Postal Ballot Along With Scrutinizer''s Report

Pursuant to Sections 110 and 108 of the Companies Act, 2013 read with the Companies (Management and Administration) Rules, 2014, the approval of the Members was sought for the re -appointment of Mr. Yogesh Shah (DIN:06396150) as an Executive Director of the Company, via ordinary resolution, as detailed in the Postal Ballot Notice dated 15th March 2023. In compliance with Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015; we are enclosing herewith the voting results of the Postal Ballot along with the Scrutinizer''s Report. Considering the votes cast in favour of the resolution, the resolutions was carried (passed) with requisite majority. We request to take the same on your record.
17-04-2023
Bigul

LYKA LABS LTD. - 500259 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015; the Company has received an intimation from M/s. Link Intime India Private Limited ('Registrar and Share Transfer Agent' of the Company) pertaining to loss of share certificates.
13-04-2023
Bigul

LYKA LABS LTD. - 500259 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 18Th April 2023

LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/04/2023 ,inter alia, to consider and approve A meeting of the Board of Directors of the Company is schedule to be held on Tuesday, 18th April 2023 at 11:30 a.m. (IST) at 125 - Charkop Road, Charkop Industrial Estate, Kandivali West, Mumbai - 400 067, inter alia: to allot and issue 24,00,000 Equity Shares upon conversion of 24,00,000 Warrants to Ipca Laboratories Limited, part of a 'Promoter Group'.
11-04-2023
Bigul

LYKA LABS LTD. - 500259 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015; the Company has issued duplicate share certificate.
11-04-2023
Bigul

LYKA LABS LTD. - 500259 - Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015

Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015; enclosing herewith a certificate for the year ended 31st March 2023.
10-04-2023
Bigul

LYKA LABS LTD. - 500259 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018; enclosing herewith a certificate for the quarter ended 31st March 2023, as received from Link Intime India Private Limited, the Registrar and Share Transfer Agent of the Company.
10-04-2023
Next Page
Close

Let's Open Free Demat Account